| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 04/07/2011 | US20110081688 Water-Soluble Rhodamine Dyes Conjugates |
| 04/06/2011 | EP2305291A1 Use of proteasome inhibitors for the treatment of HIV infections |
| 04/06/2011 | EP2305219A1 Pharmaceutical preparations coated with a copolyvidone-containing coating |
| 04/06/2011 | EP2304043A1 Hiv protease inhibitors and methods for using |
| 04/06/2011 | EP2303893A1 Tricyclic indole derivatives and methods of use thereof |
| 04/06/2011 | EP1888592B1 Spiroheterocyclic compounds and their uses as therapeutic agents |
| 04/06/2011 | EP1857107B1 Preventive or therapeutic agent for cardiac dysfunction or myocardial damage caused by ischemia or ischemia-reperfusion |
| 04/06/2011 | CN1812980B Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics |
| 04/06/2011 | CN102007130A Antibiotic tetrahydro-beta-carboline derivatives |
| 04/06/2011 | CN102007129A Derivatives of galantamine as pro-drugs for the treatment of human brain diseases |
| 04/06/2011 | CN102007128A Tricyclic antibiotics |
| 04/06/2011 | CN102007127A Furo- and thieno [3,2-c] pyridines |
| 04/06/2011 | CN102007124A Pyrimidine-2-amine compounds and their use as inhibitors of jak kinases |
| 04/06/2011 | CN102002050A Bisbenzylisoquinoline derivative and preparation and application thereof |
| 04/06/2011 | CN102002041A Phenanthroindolizidine alkaloid derivates and salt thereof as well as application of anti-cancer activity of phenanthroindolizidine alkaloid derivates and salt thereof |
| 04/06/2011 | CN101486710B Method for synthesizing 3-halogenated indolizine compound |
| 04/06/2011 | CN101468995B Isoquinolinium compound or its salts, pharmaceutical composition containing the same, preparation and use thereof |
| 04/06/2011 | CN101056861B Carbamoyl-substituted spiro derivative |
| 04/05/2011 | US7919517 Indazole derivatives |
| 04/05/2011 | US7919493 A compound having a fused ecteinascidin five ring system with a 1,4 bridge; anticarcinogenic agent |
| 04/05/2011 | CA2515730C Pyrrolidinohydrochinazolines |
| 04/05/2011 | CA2514681C Methods and compositions for inhibition of angiogenesis |
| 04/05/2011 | CA2475432C 2,4,6-triamino-1,3,5-triazine derivative |
| 04/05/2011 | CA2447909C Use of proteasome inhibitors to treat dry eye disorders |
| 04/05/2011 | CA2344168C Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors |
| 03/31/2011 | WO2011036889A1 Heterocyclic compound |
| 03/31/2011 | WO2011035518A1 Pyrimidine derivatives and analogs, preparation method and use thereof |
| 03/31/2011 | WO2011035434A1 Gallium complex anti microbial compounds, compositions, uses and methods |
| 03/31/2011 | WO2011035416A1 Hsp90 modulating compounds, compositions, methods and uses |
| 03/31/2011 | US20110077262 Novel spirochromanone carboxylic acids |
| 03/31/2011 | US20110077246 Bicyclic heterocyclic compounds pharmaceutical compositions containing these compounds, their use and process for preparing the same |
| 03/31/2011 | US20110077193 Artemisinin Derivatives with Natural Amino Acids, Peptides, and Amino Sugars for the Treatment of Infection and Topical Condition in Mammals |
| 03/31/2011 | US20110076292 Benzoxazepin pi3k inhibitor compounds and methods of use |
| 03/30/2011 | EP2301926A1 Halogen compound, polycyclic compound, and organic electroluminescence element comprising the polycyclic compound |
| 03/30/2011 | EP2301921A1 Polycyclic compound and organic electroluminescent device using the same |
| 03/30/2011 | EP2301565A1 Use of proteasome inhibitors for the treatment of viral infections |
| 03/30/2011 | EP2300471A1 Substituted pyridin-4-yl-methyl sulfonamidesas fungicides |
| 03/30/2011 | EP1277738B1 Condensed heteroaryl derivatives |
| 03/30/2011 | CN101998958A Thieno-and furo-pyrimidine modulators of the histamine h4 receptor |
| 03/30/2011 | CN101993446A Novel benzanthracene cyclic compounds and preparation method and use thereof |
| 03/29/2011 | US7915402 Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the C-ring |
| 03/29/2011 | US7915300 Cysteine protease inhibitors |
| 03/29/2011 | US7915291 Hepatitis C virus inhibitors |
| 03/29/2011 | US7915282 Preparation by intramolecular cyclization |
| 03/29/2011 | US7915276 Berberrubine derivatives having antifungal activities |
| 03/29/2011 | CA2494892C Denatured carob flour (dcf) with a low content of soluble tannins and sugars, meant for human consumption and process to obtain it |
| 03/29/2011 | CA2489276C Tricyclic steroid hormone nuclear receptor modulators |
| 03/29/2011 | CA2390164C Substituted 4h-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 03/24/2011 | WO2011033265A1 Pharmaceutical compounds |
| 03/24/2011 | WO2011033055A1 Fused triazole amines as p2x7 modulators |
| 03/24/2011 | US20110071301 Abeta-binding small molecules |
| 03/24/2011 | US20110071179 Macrocyclic inhibitors of jak |
| 03/24/2011 | US20110071136 Novel tricyclic protein kinase modulators |
| 03/24/2011 | US20110071128 Novel imidazopyridines |
| 03/24/2011 | US20110071097 Cephalotaxus esters, methods of synthesis, and uses thereof |
| 03/24/2011 | CA2774015A1 Treatment of cancer |
| 03/24/2011 | CA2772105A1 Fused triazole amines as p2x7 modulators |
| 03/23/2011 | EP2298774A1 Halogen compound, polycyclic compound and organic electroluminescent element using the polycyclic compound |
| 03/23/2011 | EP2298306A1 A method of analgesia |
| 03/23/2011 | EP2298305A1 4-(N-Phenylamino)-quinazolines/quinolines as inhibitors of tyrosine kinases |
| 03/23/2011 | EP2298300A1 Compositions for inhibition of anglogenesis comprising thalidomide and aspirin |
| 03/23/2011 | EP2297164A1 Pyrazolospiroketone acetyl-coa carboxylase inhibitors |
| 03/23/2011 | EP2297163A1 Pyrazolospiroketone acetyl-c0a carboxylase inhibitors |
| 03/23/2011 | EP2297162A1 Compounds |
| 03/23/2011 | EP2297150A1 Substituted quinazolines as blood platelet lowering agents |
| 03/23/2011 | EP2297146A1 Substituted quinazolines |
| 03/23/2011 | EP2297107A1 Ý4-(1-amino-ethyl) -cyclohexyl¨-methyl-amine and ý6-(1-amino-ethyl) -tetrahydro- pyran-3-yl¨-methyl-amine derivatives as antibacterials |
| 03/23/2011 | EP2086643B1 Compounds which potentiate ampa receptor and uses thereof in medicine |
| 03/23/2011 | EP1087960B1 Macrocyclic analogs and methods of their use and preparation |
| 03/23/2011 | CN101990542A Cyclopamine tartrate salt and uses thereof |
| 03/23/2011 | CN101990541A Fused heteroaryl modulators of glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof |
| 03/23/2011 | CN101987853A Preparation method of coumarin-102 |
| 03/23/2011 | CN101987852A Method for preparing coumarin-340 |
| 03/22/2011 | US7910737 Process for the manufacturing of 7-ethyl-10-hydroxy camptothecin |
| 03/22/2011 | US7910731 Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them |
| 03/22/2011 | US7910712 Fungal cell wall synthesis gene |
| 03/22/2011 | US7910616 Proteasome inhibitors |
| 03/22/2011 | US7910615 Prophylactic or therapeutic agent for diabetic maculopathy |
| 03/22/2011 | US7910602 treatment and prevention of chronic heart failure, hypertension, myocardial ischemia and hepatitis C virus (HCV) infections, and for the prevention of opiate addiction |
| 03/22/2011 | US7910597 platelet lowering agent anagrelide especially 3-and 5-substituted analogues, with reduced potential for cardiovascular side-effects; imidazo[2,1-b]quinazolin-2-one derivatives; by inhibiting megakaryocytopoeisis; antiproliferative agents |
| 03/22/2011 | US7910593 Water-soluble prodrugs |
| 03/22/2011 | US7910561 Inhibitors of Akt activity |
| 03/22/2011 | CA2454228C Radiolabeled neuropeptide y y5 receptor antagonists |
| 03/22/2011 | CA2432572C Oxybenzamides derivatives as factor xa inhibitors |
| 03/17/2011 | WO2011031743A1 Antibacterial fluoroquinolone analogs |
| 03/17/2011 | WO2011031740A1 Antibacterial fluoroquinolone analogs |
| 03/17/2011 | WO2011030645A1 Photopolymerizable composition, color filter, method for producing same, solid-state image pickup element, liquid crystal display device, lithographic printing original plate, and novel compound |
| 03/17/2011 | WO2011029279A1 Fused heteroaryl compounds, preparation method and use thereof |
| 03/17/2011 | US20110065714 Substituted quinazolines |
| 03/17/2011 | US20110065713 Benzazole Derivatives, Compositions, and Methods of Use as B-Secretase Inhibitors |
| 03/17/2011 | US20110065703 Novel agents of calcium ion channel modulators |
| 03/17/2011 | US20110065690 Compositions and methods for treatment of leukemia |
| 03/16/2011 | EP2295503A1 Dibenzorhodamine dyes useful as fluorescent labelling agents |
| 03/16/2011 | EP2295442A2 Inhibitors of interleukin-1beta converting enzyme |
| 03/16/2011 | EP2295436A1 2-Phenyl-subsitituted Imidazotriazinones as Phosphodiesterase V inhibitors |
| 03/16/2011 | EP2295415A1 Quinazoline derivatives |
| 03/16/2011 | EP2294054A1 A preparation method of (4s,5r)-semiester |
| 03/16/2011 | EP1699761B1 Cb1 modulator compounds |
| 03/16/2011 | CN101985449A Coumarin derivative, and preparation method and use thereof as anti-cancer medicament |
| 03/15/2011 | US7906646 Spirocyclic heterocyclic derivatives and methods of their use |